Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Fereshteh Shiri, Somayeh Pirhadi & Azita Rahmani. (2018) Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening. Journal of Receptors and Signal Transduction 38:1, pages 37-47.
Read now
Read now
Shreekant Deshpande, Rinki Singh, Mohammad Goodarzi, Seturam B. Katti & Yenamandra S. Prabhakar. (2011) Consensus features of CP-MLR and GA in modeling HIV-1 RT inhibitory activity of 4-benzyl/benzoylpyridin-2-one analogues. Journal of Enzyme Inhibition and Medicinal Chemistry 26:5, pages 696-705.
Read now
Read now
NajimA. Al-Masoudi, YaseenA. Al-Soud, IbrahimA. I. Ali, Thilo Schuppler, Christoph Pannecouque & Erik De Clercq. (2007) New AZT Analogues Having 5′-Alkylsulfonyl Groups: Synthesis and Anti-HIV Activity. Nucleosides, Nucleotides & Nucleic Acids 26:3, pages 223-230.
Read now
Read now
Rino Ragno, Antonia Coluccia, Giuseppe La Regina & Romano Silvestri. (2007) Indolyl aryl sulphones as HIV-1 reverse transcriptase inhibitors: docking and 3D QSAR studies. Expert Opinion on Drug Discovery 2:1, pages 87-114.
Read now
Read now
Bryan McGee, Nathalie Smith & Francesca Aweeka. (2006) HIV Pharmacology: Barriers to the Eradication of HIV from the CNS. HIV Clinical Trials 7:3, pages 142-153.
Read now
Read now
Claude Fortin, Véronique Joly & Patrick Yeni. (2006) Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adults. Expert Opinion on Emerging Drugs 11:2, pages 217-230.
Read now
Read now
Kurt Vermeire & Dominique Schols. (2005) Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor. Expert Opinion on Investigational Drugs 14:10, pages 1199-1212.
Read now
Read now
Giovanni Di Perri, Diego Aguilar Marucco, Alessandra Mondo, Daniel Gonzalez de Requena, Sabrina Audagnotto, Federico Gobbi & Stefano Bonora. (2005) Drug–drug interactions and tolerance in combining antituberculosis and antiretroviral therapy. Expert Opinion on Drug Safety 4:5, pages 821-836.
Read now
Read now
Articles from other publishers (114)
Nana Tian, Dongchen Chu, Hongjun Wang & Hong Yan. (2023) Synthesis and anti-HIV-1 activity evaluation of Keggin-type polyoxometalates with amino acid as organic cations. Bioorganic & Medicinal Chemistry Letters 91, pages 129380.
Crossref
Crossref
Madan Kumar & Avijit Goswami. (2023)
Tunable Regio- and Stereoselective Synthesis of
Z
-Acrylonitrile Indoles and 3-Cyanoquinolines from 2-Alkynylanilines and Alkynylnitriles
. Organic Letters 25:18, pages 3254-3259.
Crossref
Crossref
Reagon Karki, Yojana Gadiya, Andrea Zaliani & Philip Gribbon. (2023) Mpox Knowledge Graph: a comprehensive representation embedding chemical entities and associated biology of Mpox. Bioinformatics Advances 3:1.
Crossref
Crossref
Yonggang Jiang, Bijun Wang, Dongxiang Liu, Dazhen Xia, Zhengfen Liu, Liang Li, Guogang Deng & Xiaodong Yang. (2022) Aryl acrylonitriles synthesis enabled by palladium-catalyzed α-alkenylation of arylacetonitriles with vinyl halides/triflates. Frontiers in Chemistry 10.
Crossref
Crossref
Ruogang Zhao, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang & Bo Zhang. (2022) Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics 14:8, pages 1541.
Crossref
Crossref
Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, Vegard Myhre, Erlend Ravlo, Gerda D. Kaynova, Eva Zusinaite, Judith M. White, Stephen J. Polyak, Valentyn Oksenych, Marc P. Windisch, Qiuwei Pan, Eglė Lastauskienė, Astra Vitkauskienė, Algimantas Matukevičius, Tanel Tenson, Magnar Bjørås & Denis E. Kainov. (2022) Mono- and combinational drug therapies for global viral pandemic preparedness. iScience 25:4, pages 104112.
Crossref
Crossref
Rakhi S. Vishwakarma, M. Lakshmi Kantam & Virendra K. Rathod. (2022) Fluorapatite‐Supported Palladium Catalyst for the Synthesis of Alkenyl Nitriles. ChemNanoMat 8:3.
Crossref
Crossref
Antón L. Martínez, José Brea, Eduardo Domínguez, María J. Varela, Marta Cimadevila, Catarina Allegue, Raquel Cruz, Xavier Monroy, Manuel Merlos, Javier Burgueño, Ángel Carracedo & María I. Loza. (2021) Identification of Novel Regulators of Zalcitabine-Induced Neuropathic Pain. ACS Chemical Neuroscience 12:14, pages 2619-2628.
Crossref
Crossref
Runyou Ye, Maoshuai Zhu, Xufei Yan, Yang Long, Ying Xia & Xiangge Zhou. (2021) Pd(II)-Catalyzed C═C Bond Cleavage by a Formal Group-Exchange Reaction. ACS Catalysis 11:14, pages 8678-8683.
Crossref
Crossref
Xi-Rui Zhou, Ye Liu, Zhentao Huang, Qingxin Yao, Fangfei He & Yuan Gao. (2021) Gag Protein Oriented Supramolecular Nets as Potential HIV Traps. Bioconjugate Chemistry 32:1, pages 106-110.
Crossref
Crossref
Somayyeh Heydari, Davood Habibi, Ali Reza Faraji, Hassan keypour & Masoumeh Mahmoudabadi. (2021) An overview on the progress and development on the palladium catalyzed direct cyanation. Inorganica Chimica Acta 514, pages 119956.
Crossref
Crossref
Jun-Gyu Park, Ginés Ávila-Pérez, Ferralita Madere, Thomas A. Hilimire, Aitor Nogales, Fernando Almazán & Luis Martínez-Sobrido. (2019) Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid. Frontiers in Microbiology 10.
Crossref
Crossref
Jitendra Gurjar, Jorick Bater & Valery V. Fokin. (2019) Sulfuryl Fluoride Mediated Conversion of Aldehydes to Nitriles. Chemistry – A European Journal 25:8, pages 1906-1909.
Crossref
Crossref
Pulok K. Mukherjee. 2019. Quality Control and Evaluation of Herbal Drugs. Quality Control and Evaluation of Herbal Drugs
599
628
.
Sonal Modak, Deepak Sehgal & Jayaraman Valadi. 2019. Global Virology III: Virology in the 21st Century. Global Virology III: Virology in the 21st Century
1
39
.
Manthena Chaitanya & Pazhamalai Anbarasan. (2018) Recent developments and applications of cyanamides in electrophilic cyanation. Organic & Biomolecular Chemistry 16:39, pages 7084-7103.
Crossref
Crossref
Rafał Gawin, Andrzej Tracz, Michał Chwalba, Anna Kozakiewicz, Bartosz Trzaskowski & Krzysztof Skowerski. (2017) Cyclic Alkyl Amino Ruthenium Complexes—Efficient Catalysts for Macrocyclization and Acrylonitrile Cross Metathesis. ACS Catalysis 7:8, pages 5443-5449.
Crossref
Crossref
Xuna Zhao, Tong-Xin Liu, Nana Ma, Zhiguo Zhang & Guisheng Zhang. (2016) Multicomponent reaction of pyridine, acetoacetamide/benzoylacetamides and sulfuryl chlorides: regioselective construction of 4-olefinated dihydropyridines. Tetrahedron 72:32, pages 4938-4946.
Crossref
Crossref
Zhen-Bang Chen, Fang-Ling Zhang, Qing Yuan, Hai-Fang Chen, Yong-Ming Zhu & Jing-Kang Shen. (2016) α-Iminonitrile: a new cyanating agent for the palladium catalyzed C–H cyanation of arenes. RSC Advances 6:69, pages 64234-64238.
Crossref
Crossref
Mônica M. Bastos, Carolina C.P. Costa, Talitha C. Bezerra, Fernando de C. da Silva & Núbia Boechat. (2016) Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry. European Journal of Medicinal Chemistry 108, pages 455-465.
Crossref
Crossref
Utsab Debnath, Saroj Verma, Pankaj Singh, Kavita Rawat, Satish K. Gupta, Raj K. Tripathi, Hefazat H. Siddiqui, Seturam B. Katti & Yenamandra S. Prabhakar. (2015) Synthesis, Biological Evaluation and Molecular Modeling Studies of New 2,3-Diheteroaryl Thiazolidin-4-Ones as NNRTIs. Chemical Biology & Drug Design 86:5, pages 1285-1291.
Crossref
Crossref
Manthena Chaitanya & Pazhamalai Anbarasan. (2015)
Rhodium-Catalyzed Cyanation of C(sp
2
)–H Bond of Alkenes
. Organic Letters 17:15, pages 3766-3769.
Crossref
Crossref
Jean A. Bernatchez, Rakesh Paul, Egor P. Tchesnokov, Marianne Ngure, Greg L. Beilhartz, Albert M. Berghuis, Rico Lavoie, Lianhai Li, Anick Auger, Roman A. Melnyk, Jay A. Grobler, Michael D. Miller, Daria J. Hazuda, Sidney M. Hecht & Matthias Götte. (2015) Derivatives of Mesoxalic Acid Block Translocation of HIV-1 Reverse Transcriptase. Journal of Biological Chemistry 290:3, pages 1474-1484.
Crossref
Crossref
Philippe Bisseret, Guillaume Duret & Nicolas Blanchard. (2014) Chopping unfunctionalized carbon–carbon bonds: a new paradigm for the synthesis of organonitriles. Org. Chem. Front. 1:7, pages 825-833.
Crossref
Crossref
Alexandre Pradal & Gwilherm Evano. (2014) A vinylic Rosenmund–von Braun reaction: practical synthesis of acrylonitriles. Chem. Commun. 50:80, pages 11907-11910.
Crossref
Crossref
Erik De Clercq. (2013) Dancing with chemical formulae of antivirals: A personal account. Biochemical Pharmacology 86:6, pages 711-725.
Crossref
Crossref
Jay Parrish, Leah Tong, Michael Wang, Xiaowu Chen, Eric B. Lansdon, Carina Cannizzaro, Xubin Zheng, Manoj C. Desai & Lianhong Xu. (2013) Synthesis and biological evaluation of phosphonate analogues of nevirapine. Bioorganic & Medicinal Chemistry Letters 23:5, pages 1493-1497.
Crossref
Crossref
Kamalendra Singh, Bruno Marchand, Devendra K. Rai, Bechan Sharma, Eleftherios Michailidis, Emily M. Ryan, Kayla B. Matzek, Maxwell D. Leslie, Ariel N. Hagedorn, Zhe Li, Pieter R. Norden, Atsuko Hachiya, Michael A. Parniak, Hong-Tao Xu, Mark A. Wainberg & Stefan G. Sarafianos. (2012) Biochemical Mechanism of HIV-1 Resistance to Rilpivirine. Journal of Biological Chemistry 287:45, pages 38110-38123.
Crossref
Crossref
Lihua Yao, Bhaskar Pitta, P. C. Ravikumar, Matthew Purzycki & Fraser F. Fleming. (2012) Transmissive Olefination Route to Putative “Morinol I” Lignans. The Journal of Organic Chemistry 77:7, pages 3651-3657.
Crossref
Crossref
Elena Cichero & Paola Fossa. (2011) Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. Journal of Molecular Modeling 18:4, pages 1573-1582.
Crossref
Crossref
Nasser Goudarzi, Mohammad Goodarzi & Tao Chen. (2011) QSAR prediction of HIV inhibition activity of styrylquinoline derivatives by genetic algorithm coupled with multiple linear regressions. Medicinal Chemistry Research 21:4, pages 437-443.
Crossref
Crossref
Surendra Kumar, Vineet Singh & Meena Tiwari. (2010) QSAR modeling of the inhibition of reverse transcriptase enzyme with benzimidazolone analogs. Medicinal Chemistry Research 20:9, pages 1530-1541.
Crossref
Crossref
Tobias Gr?wert, Michael Groll, Felix Rohdich, Adelbert Bacher & Wolfgang Eisenreich. (2011) Biochemistry of the non-mevalonate isoprenoid pathway. Cellular and Molecular Life Sciences 68:23, pages 3797-3814.
Crossref
Crossref
Erik De Clercq. 2011. HIV‐1 Integrase. HIV‐1 Integrase
1
14
.
Elena Cichero, Laura Buffa & Paola Fossa. (2010) 3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses. Journal of Molecular Modeling 17:7, pages 1537-1550.
Crossref
Crossref
Violeta I. Pérez‐Nueno & David W. Ritchie. (2010) Applying in silico tools to the discovery of novel CXCR4 inhibitors. Drug Development Research 72:1, pages 95-111.
Crossref
Crossref
Marjan A. Rafiee & Tayyebe Partoee. (2011) Investigation of the Binding Affinity between Styrylquinoline Inhibitors and HIV Integrase Using Calculated Nuclear Quadrupole Coupling Constant (NQCC) Parameters (A Theoretical ab initio Study). Bulletin of the Korean Chemical Society 32:1, pages 208-212.
Crossref
Crossref
Fraser F. Fleming, Lihua Yao, P. C. Ravikumar, Lee Funk & Brian C. Shook. (2010) Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore. Journal of Medicinal Chemistry 53:22, pages 7902-7917.
Crossref
Crossref
Donald J. AbrahamErik De Clercq. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
139
168
.
Sofia Pettersson, Violeta I. Pérez-Nueno, Maria Pau Mena, Bonaventura Clotet, José A. Esté, José I. Borrell & Jordi Teixidó. (2010) Novel Monocyclam Derivatives as HIV Entry Inhibitors: Design, Synthesis, Anti-HIV Evaluation, and Their Interaction with the CXCR4 Co-receptor. ChemMedChem 5:8, pages 1272-1281.
Crossref
Crossref
Jerome Guillemont, Luc Geeraert, Jan Heeres & Paul J. Lewi. 2010. Analogue-Based Drug Discovery II. Analogue-Based Drug Discovery II
409
441
.
Brian I. Bliss, Feryan Ahmed, Subashree Iyer, Weimin Lin, Joel Walker & He Zhao. (2010) Convenient preparation of 4-aryl-2-(heteroarylamino)pyrimidines and 4-anilino-2-(heteroarylamino)pyrimidines. Tetrahedron Letters 51:25, pages 3259-3262.
Crossref
Crossref
Sara Cesarini, Andrea Spallarossa, Angelo Ranise, Silvia Schenone, Paolo La Colla, Gabriella Collu, Giuseppina Sanna & Roberta Loddo. (2009) (Hetero)aroyl esters of 2-(N-phthalimido)ethanol and analogues: parallel synthesis, anti-HIV-1 activity and cytotoxicity. Medicinal Chemistry Research 19:4, pages 311-336.
Crossref
Crossref
Kamalendra Singh, Bruno Marchand, Karen A. Kirby, Eleftherios Michailidis & Stefan G. Sarafianos. (2010) Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase. Viruses 2:2, pages 606-638.
Crossref
Crossref
Masaaki Takahashi, Atsushi Hirano, Nami Okubo, Eri Kinoshita, Toshiharu Nomura & Tsuguhiro Kaneda. (2010) Development and application of a simple LC-MS method for the determination of plasma maraviroc concentrations. The Journal of Medical Investigation 57:3,4, pages 245-250.
Crossref
Crossref
Samir Abdurahman, Ákos Végvári, Michael Levi, Stefan Höglund, Marita Högberg, Weimin Tong, Ivan Romero, Jan Balzarini & Anders Vahlne. (2009) Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology. Retrovirology 6:1.
Crossref
Crossref
Erik De Clercq. (2009) The history of antiretrovirals: key discoveries over the past 25 years. Reviews in Medical Virology 19:5, pages 287-299.
Crossref
Crossref
P. C. F. Oyston, M. A. Fox, S. J. Richards & G. C. Clark. (2009) Novel peptide therapeutics for treatment of infections. Journal of Medical Microbiology 58:8, pages 977-987.
Crossref
Crossref
Anna-Maria Monforte, Patrizia Logoteta, Stefania Ferro, Laura De Luca, Nunzio Iraci, Giovanni Maga, Erik De Clercq, Christophe Pannecouque & Alba Chimirri. (2009) Design, synthesis, and structure?activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. Bioorganic & Medicinal Chemistry 17:16, pages 5962-5967.
Crossref
Crossref
Elena Cichero, Sara Cesarini, Andrea Spallarossa, Luisa Mosti & Paola Fossa. (2009) Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses. Journal of Molecular Modeling 15:7, pages 871-884.
Crossref
Crossref
Dirk Jochmans, Johan Vingerhoets, Eric Arnoult, Luc Geeraert & Jérôme Guillemont. 2009. Antiviral Research. Antiviral Research
33
50
.
Violeta I. Pérez-Nueno, Sofia Pettersson, David W. Ritchie, José I. Borrell & Jordi Teixidó. (2009) Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening. Journal of Chemical Information and Modeling 49:4, pages 810-823.
Crossref
Crossref
Monica Donghi, Olaf D. Kinzel & Vincenzo Summa. (2009) 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates—A new class of HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters 19:7, pages 1930-1934.
Crossref
Crossref
Elena Cichero, Sara Cesarini, Andrea Spallarossa, Luisa Mosti & Paola Fossa. (2008) Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor. Journal of Molecular Modeling 15:4, pages 357-367.
Crossref
Crossref
Hepan Tan & A. J. Rader. (2009) Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120. Proteins: Structure, Function, and Bioinformatics 74:4, pages 881-894.
Crossref
Crossref
Hui-Chen Hung, Ching-Ping Tseng, Jinn-Moon Yang, Yi-Wei Ju, Sung-Nain Tseng, Yen-Fu Chen, Yu-Sheng Chao, Hsing-Pang Hsieh, Shin-Ru Shih & John T.-A. Hsu. (2009) Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Research 81:2, pages 123-131.
Crossref
Crossref
Erik De Clercq. (2008) The discovery of antiviral agents: Ten different compounds, ten different stories. Medicinal Research Reviews 28:6, pages 929-953.
Crossref
Crossref
Maxim B. Nawrozkij, Dante Rotili, Domenico Tarantino, Giorgia Botta, Alexandre S. Eremiychuk, Ira Musmuca, Rino Ragno, Alberta Samuele, Samantha Zanoli, Mercedes Armand-Ugón, Imma Clotet-Codina, Ivan A. Novakov, Boris S. Orlinson, Giovanni Maga, José A. Esté, Marino Artico & Antonello Mai. (2008)
5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3
H
)-ones, a Series of Anti-HIV-1 Agents of the Dihydro-alkoxy-benzyl-oxopyrimidine Family with Peculiar Structure−Activity Relationship Profile
. Journal of Medicinal Chemistry 51:15, pages 4641-4652.
Crossref
Crossref
Roy T. SteigbigelDavid A. CooperPrincy N. KumarJoseph E. EronMauro SchechterMartin MarkowitzMona R. LoutfyJeffrey L. LennoxJose M. GatellJurgen K. RockstrohChristine KatlamaPatrick YeniAdriano LazzarinBonaventura ClotetJing ZhaoJoshua ChenDesmond M. RyanRand R. RhodesJohn A. KillarLucinda R. GildeKim M. StrohmaierAnne R. MeibohmMichael D. MillerDaria J. HazudaMichael L. NesslyMark J. DiNubileRobin D. IsaacsBach-Yen NguyenHedy Teppler. (2008) Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection. New England Journal of Medicine 359:4, pages 339-354.
Crossref
Crossref
Bachir Latli, Matt Hrapchak, John A. Easter, Wayne T. Stolle, Karl Grozinger, Dhileepkumar Krishnamurthy & Chris H. Senanayake. (2008)
Synthesis of [
14
C] ‐ and [
13
C
6
]‐labeled tipranavir and its potential hydroxyl metabolite and the glucuronide conjugate
. Journal of Labelled Compounds and Radiopharmaceuticals 51:8, pages 314-320.
Crossref
Crossref
Sara Cesarini, Andrea Spallarossa, Angelo Ranise, Silvia Schenone, Olga Bruno, Paolo La Colla, Laura Casula, Gabriella Collu, Giuseppina Sanna & Roberta Loddo. (2008) Parallel one-pot synthesis and structure?activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry 16:12, pages 6353-6363.
Crossref
Crossref
Raimund Fromme, Zivile Katiliene, Petra Fromme & Giovanna Ghirlanda. (2008) Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 Å resolution. Protein Science 17:5, pages 939-944.
Crossref
Crossref
Cristina Helena dos Reis Serra, Eunice Emiko Mori Koono, Eunice Kazue Kano, Simone Grigoleto Schramm, Yara Popst Armando & Valentina Porta. (2008) Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy brazilian volunteers: An open-label, randomized, single-dose, two-way crossover study. Clinical Therapeutics 30:5, pages 902-908.
Crossref
Crossref
Erik De Clercq & Hugh J Field. (2008)
Antiviral Chemistry & Chemotherapy
's Current Antiviral Agents FactFile (2nd Edition): Retroviruses and Hepadnaviruses
. Antiviral Chemistry and Chemotherapy 19:2, pages 75-105.
Crossref
Crossref
Roger G. Ptak, Philippe A. Gallay, Dirk Jochmans, Andrew P. Halestrap, Urs T. Ruegg, Luke A. Pallansch, Michael D. Bobardt, Marie-Pierre de Béthune, Johan Neyts, Erik De Clercq, Jean-Maurice Dumont, Pietro Scalfaro, Kamel Besseghir, Roland M. Wenger & Brigitte Rosenwirth. (2008) Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent. Antimicrobial Agents and Chemotherapy 52:4, pages 1302-1317.
Crossref
Crossref
Violeta I. Pérez-Nueno, David W. Ritchie, Obdulia Rabal, Rosalia Pascual, Jose I. Borrell & Jordi Teixidó. (2008) Comparison of Ligand-Based and Receptor-Based Virtual Screening of HIV Entry Inhibitors for the CXCR4 and CCR5 Receptors Using 3D Ligand Shape Matching and Ligand−Receptor Docking. Journal of Chemical Information and Modeling 48:3, pages 509-533.
Crossref
Crossref
Claire GondeauLaurent ChaloinAndrea VargaBéatrice RoyPerrine LallemandChristian PérigaudTom BarmanMária VasCorinne Lionne. (2008)
Differences in the Transient Kinetics of the Binding of
d
-ADP and its Mirror Image
l
-ADP to Human 3-Phosphoglycerate Kinase Revealed by the Presence of 3-Phosphoglycerate
. Biochemistry 47:11, pages 3462-3473.
Crossref
Crossref
Ester Muraglia, Olaf Kinzel, Cristina Gardelli, Benedetta Crescenzi, Monica Donghi, Marco Ferrara, Emanuela Nizi, Federica Orvieto, Giovanna Pescatore, Ralph Laufer, Odalys Gonzalez-Paz, Annalise Di Marco, Fabrizio Fiore, Edith Monteagudo, Massimiliano Fonsi, Peter J. Felock, Michael Rowley & Vincenzo Summa. (2008) Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors. Journal of Medicinal Chemistry 51:4, pages 861-874.
Crossref
Crossref
Muhammad Mukhtar, Mohammad Arshad, Mahmood Ahmad, Roger J. Pomerantz, Brian Wigdahl & Zahida Parveen. (2008) Antiviral potentials of medicinal plants. Virus Research 131:2, pages 111-120.
Crossref
Crossref
Masaaki Takahashi, Mitsuru Konishi, Yuichi Kudaka, Naoya Okumura, Atsushi Hirano, Nami Terahata, Kazuhide Banno & Tsuguhiro Kaneda. (2008) A Conventional LC-MS Method Developed for the Determination of Plasma Raltegravir Concentrations. Biological & Pharmaceutical Bulletin 31:8, pages 1601-1604.
Crossref
Crossref
Hongzong Si, Shuping Yuan, Kejun Zhang, Aiping Fu, Yun-Bo Duan & Zhide Hu. (2008) Quantitative structure activity relationship study on EC50 of anti-HIV drugs. Chemometrics and Intelligent Laboratory Systems 90:1, pages 15-24.
Crossref
Crossref
Yongqiang Lin, Xinyong Liu, Renzhang Yan, Jin Li, Christophe Pannecouque, Myriam Witvrouw & Erik De Clercq. (2008) Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs). Bioorganic & Medicinal Chemistry 16:1, pages 157-163.
Crossref
Crossref
Koteshwara Mudigonda, Raju Jukanti, Shashank S. Apte, Veerabrahma Kishan, Santosh Maurya, Vishwottam Kandikere & Ramakrishna Nirogi. (2007) Rapid and simple liquid chromatography tandem mass spectrometry method for the quantification of zidovudine in rat plasma. Biomedical Chromatography 22:1, pages 20-27.
Crossref
Crossref
Erik De Clercq. (2007) The design of drugs for HIV and HCV. Nature Reviews Drug Discovery 6:12, pages 1001-1018.
Crossref
Crossref
Kenji Izumi, Mikio Kabaki, Masaaki Uenaka & Sumio Shimizu. (2007) One-Step Synthesis of 5-(4-Fluorobenzyl)-2-furyl Methyl Ketone: A Key Intermediate of HIV-Integrase Inhibitor S-1360. Organic Process Research & Development 11:6, pages 1059-1061.
Crossref
Crossref
Sumio Shimizu, Takeshi Endo, Kenji Izumi & Hidenori Mikamiyama. (2007) Development of HIV-Integrase Inhibitor S-1360: Selection of the Protecting Group on the 1,2,4-Triazole Ring. Organic Process Research & Development 11:6, pages 1055-1058.
Crossref
Crossref
Antonello MaiMarino ArticoDante RotiliDomenico TarantinoImma Clotet-CodinaMercedes Armand-UgónRino RagnoSilvia SimeoniGianluca SbardellaMaxim B. NawrozkijAlberta SamueleGiovanni MagaJosé A. Esté. (2007)
Synthesis and Biological Properties of Novel 2-Aminopyrimidin-4(3
H
)-ones Highly Potent against HIV-1 Mutant Strains
. Journal of Medicinal Chemistry 50:22, pages 5412-5424.
Crossref
Crossref
Jochen Woicke, Stephen K. Durham & Mark G. Mense. (2007) Lobucavir-induced proliferative changes in mice. Experimental and Toxicologic Pathology 59:3-4, pages 197-204.
Crossref
Crossref
Hui XieDanny NgSergey N. SavinovBarna DeyPeter D. KwongRichard WyattAmos B. SmithWayne A. Hendrickson. (2007) Structure−Activity Relationships in the Binding of Chemically Derivatized CD4 to gp120 from Human Immunodeficiency Virus. Journal of Medicinal Chemistry 50:20, pages 4898-4908.
Crossref
Crossref
Géry Dams, Koen Van Acker, Emmanuel Gustin, Inge Vereycken, Lieve Bunkens, Pascale Holemans, Liesbet Smeulders, Reginald Clayton, Asa Ohagen & Kurt Hertogs. (2007) A Time-Resolved Fluorescence Assay to Identify Small-Molecule Inhibitors of HIV-1 Fusion. SLAS Discovery 12:6, pages 865-874.
Crossref
Crossref
S R Vlahakis, G D Bren, A Algeciras-Schimnich, S A Trushin, D J Schnepple & A D Badley. (2007) Flying in the Face of Resistance: Antiviral-independent Benefit of HIV Protease Inhibitors on T-cell Survival. Clinical Pharmacology & Therapeutics 82:3, pages 294-299.
Crossref
Crossref
Najim A Al-Masoudi, Yaseen A Al-Soud, Erik De Clercq & Christophe Pannecouque. (2016)
Nitroimidazoles Part 6. Synthesis, Structure and
in Vitro
anti-HIV Activity of New 5-substituted Piperazinyl-4-nitroimidazole Derivatives
. Antiviral Chemistry and Chemotherapy 18:4, pages 191-200.
Crossref
Crossref
Alexandre Gagnon, Ma’an H. Amad, Pierre R. Bonneau, René Coulombe, Patrick L. DeRoy, Louise Doyon, Jianmin Duan, Michel Garneau, Ingrid Guse, Araz Jakalian, Eric Jolicoeur, Serge Landry, Eric Malenfant, Bruno Simoneau & Christiane Yoakim. (2007) Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases. Bioorganic & Medicinal Chemistry Letters 17:16, pages 4437-4441.
Crossref
Crossref
A. Hombrouck, A. Hantson, B. van Remoortel, M. Michiels, J. Vercammen, D. Rhodes, V. Tetz, Y. Engelborghs, F. Christ, Z. Debyser & M. Witvrouw. (2007) Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action. Journal of Antimicrobial Chemotherapy 59:6, pages 1084-1095.
Crossref
Crossref
Reynel Cancio, Antonello Mai, Dante Rotili, Marino Artico, Gianluca Sbardella, Imma Clotet-Codina, José A. Esté, Emmanuele Crespan, Samantha Zanoli, Ulrich Hübscher, Silvio Spadari & Giovanni Maga. (2007) Slow-, Tight-Binding HIV-1 Reverse Transcriptase Non-Nucleoside Inhibitors Highly Active against Drug-Resistant Mutants. ChemMedChem 2:4, pages 445-448.
Crossref
Crossref
Beatriz Grinsztejn, Bach-Yen Nguyen, Christine Katlama, Jose M Gatell, Adriano Lazzarin, Daniel Vittecoq, Charles J Gonzalez, Joshua Chen, Charlotte M Harvey & Robin D Isaacs. (2007) Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial. The Lancet 369:9569, pages 1261-1269.
Crossref
Crossref
Jianghong Gu & Steven J. Soldin. (2007) Modification of tandem mass spectrometric method to permit simultaneous quantification of 17 anti-HIV drugs which include atazanavir and tipranavir. Clinica Chimica Acta 378:1-2, pages 222-224.
Crossref
Crossref
Bruno Marchand, Egor P. Tchesnokov & Matthias Götte. (2007) The Pyrophosphate Analogue Foscarnet Traps the Pre-translocational State of HIV-1 Reverse Transcriptase in a Brownian Ratchet Model of Polymerase Translocation. Journal of Biological Chemistry 282:5, pages 3337-3346.
Crossref
Crossref
Kimberley A. Lentz, Megan Quitko, Daniel G. Morgan, James E. GraceJr.Jr., Carol Gleason & Punit H. Marathe. (2007) Development and Validation of a Preclinical Food Effect Model. Journal of Pharmaceutical Sciences 96:2, pages 459-472.
Crossref
Crossref
Pierre R. Bonneau & Bruno Simoneau. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Jaiprakash N. Sangshetti .Parag A. Kulkarni .Devanand B. Shinde .. (2007) Spectrophotometric Determination of Didanosine in Bulk and Tablet Formulation. Trends in Applied Sciences Research 2:1, pages 71-75.
Crossref
Crossref
Venkat R. Gadhachanda, Baogen Wu, Zhiwei Wang, Kelli L. Kuhen, Jeremy Caldwell, Helmut Zondler, Harald Walter, Mark Havenhand & Yun He. (2007) 4-Aminopyrimidines as novel HIV-1 inhibitors. Bioorganic & Medicinal Chemistry Letters 17:1, pages 260-265.
Crossref
Crossref
Erik De Clercq. 2007.
1
58
.
Ponraj Prabakaran, Antony S. Dimitrov, Timothy R. Fouts & Dimiter S. Dimitrov. 2007. HIV‐1: Molecular Biology and Pathogenesis Viral Mechanisms, Second Edition. HIV‐1: Molecular Biology and Pathogenesis Viral Mechanisms, Second Edition
33
97
.
E. De Clercq. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
253
293
.
Erik De Clercq. (2006) The role of tenofovir in the prevention of HIV infections. AIDS 20:15, pages 1990-1991.
Crossref
Crossref
Koteshwara Mudigonda, Raju Jukanti, Shashank S. Apte, Devender R. Ajjala, Wishu Shrivastava, Vishwottam N. Kandikere & Ramakrishna V. S. Nirogi. (2006) HPLC quantification of the HIV‐1 protease inhibitor saquinavir in brain and testis of mice. Biomedical Chromatography 20:10, pages 1028-1032.
Crossref
Crossref
Maria N. Preobrazhenskaya & Eugenia N. Olsufyeva. (2006) Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry. Antiviral Research 71:2-3, pages 227-236.
Crossref
Crossref
Susanna Trapp, Stuart G Turville & Melissa Robbiani. (2006) Slamming the door on unwanted guests: why preemptive strikes at the mucosa may be the best strategy against HIV. Journal of Leukocyte Biology 80:5, pages 1076-1083.
Crossref
Crossref
Zhiwei Wang, Baogen Wu, Kelli L. Kuhen, Badry Bursulaya, Truc N. Nguyen, Deborah G. Nguyen & Yun He. (2006) Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters 16:16, pages 4174-4177.
Crossref
Crossref
Sammy E. Metobo, Haolun Jin, Manuel Tsiang & Choung U. Kim. (2006) Design, synthesis, and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring. Bioorganic & Medicinal Chemistry Letters 16:15, pages 3985-3988.
Crossref
Crossref
S. Kehlenbeck, U. Betz, A. Birkmann, B. Fast, A. H. Göller, K. Henninger, T. Lowinger, D. Marrero, A. Paessens, D. Paulsen, V. Pevzner, R. Schohe-Loop, H. Tsujishita, R. Welker, J. Kreuter, H. Rübsamen-Waigmann & F. Dittmer. (2006) Dihydroxythiophenes Are Novel Potent Inhibitors of Human Immunodeficiency Virus Integrase with a Diketo Acid-Like Pharmacophore. Journal of Virology 80:14, pages 6883-6894.
Crossref
Crossref
Kunisuke Izawa & Tomoyuki Onishi. (2006) Industrial Syntheses of the Central Core Molecules of HIV Protease Inhibitors. Chemical Reviews 106:7, pages 2811-2827.
Crossref
Crossref
. (2016)
Antiviral Chemistry & Chemotherapy
's Current Antiviral Agents FactFile 2006 (1st edition): The RNA Viruses with DNA Intermediates (Retroviruses)
. Antiviral Chemistry and Chemotherapy 17:3, pages 139-168.
Crossref
Crossref
. (2016)
Antiviral Chemistry & Chemotherapy's
Current Antiviral Agents FactFile 2006 (1st edition) the RNA viruses
. Antiviral Chemistry and Chemotherapy 17:3, pages 129-144.
Crossref
Crossref
. (2016)
Antiviral Chemistry & Chemotherapy
's Current Antiviral Agents FactFile 2006 (1st Edition) the DNA Viruses
. Antiviral Chemistry and Chemotherapy 17:3, pages 117-136.
Crossref
Crossref
Catherine J. Price, Julia D. George, Melissa C. Marr, Christina B. Myers, Gayle S. Bieler, Rick L. Williams & Gloria D. Jahnke. (2006) Prenatal developmental toxicity evaluation of 2′,3′-dideoxyinosine (ddI) and 2′,3′-didehydro-3′-deoxythymidine (d4T) co-administered to Swiss Albino (CD-1) mice. Birth Defects Research Part B: Developmental and Reproductive Toxicology 77:3, pages 207-215.
Crossref
Crossref
Verónica Briz, Eva Poveda & Vincent Soriano. (2006) HIV entry inhibitors: mechanisms of action and resistance pathways. Journal of Antimicrobial Chemotherapy 57:4, pages 619-627.
Crossref
Crossref
John J. Turner, Martin Fabani, Andrey A. Arzumanov, Gabriela Ivanova & Michael J. Gait. (2006) Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: Chemistry and cell delivery. Biochimica et Biophysica Acta (BBA) - Biomembranes 1758:3, pages 290-300.
Crossref
Crossref
Erik De Clercq. (2006) A guided tour through the antiviral drug field. Future Virology 1:1, pages 19-35.
Crossref
Crossref
Wieslaw M. Kazmierski, Terry P. Kenakin & Kristjan S. Gudmundsson. (2006) Peptide, Peptidomimetic and Small-molecule Drug Discovery Targeting HIV-1 Host-cell Attachment and Entry through gp120, gp41, CCR5 and CXCR4+. Chemical Biology <html_ent glyph="@amp;" ascii="&"/> Drug Design 67:1, pages 13-26.
Crossref
Crossref
Michael O'Grady, Debasish Raha, Bonnie J Hanson, Michaeline Bunting & George T Hanson. (2005) Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer. BMC Cancer 5:1.
Crossref
Crossref
Erik De Clercq. (2005) Recent highlights in the development of new antiviral drugs. Current Opinion in Microbiology 8:5, pages 552-560.
Crossref
Crossref
Roderick E. Hubbard. (2005) 3D structure and the drug-discovery process. Molecular BioSystems.
Crossref
Crossref